Substituted imidazopyr- and imidazotri-azines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481733
APP PUB NO 20090286768A1
SERIAL NO

12468188

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Fused pyridine-based bicyclic compounds having the structure of Formula I, as defined herein, pharmaceutically acceptable salts thereof, preparation, compositions, and disease treatment therewith. This abstract does not define or limit the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSI PHARMACEUTICALS INC106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crew, Andrew P North Babylon, US 86 2039
Jin, Meizhong Dix Hills, US 41 1163
Kadalbajoo, Mridula Farmingdale, US 5 108
Kleinberg, Andrew East Meadow, US 12 51
Mulvihill, Mark J East Northport, US 30 121
Wang, Jing Syosset, US 1745 13464

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00